Loading clinical trials...
Loading clinical trials...
A Pilot Study in the Treatment of Refractory Epstein-Barr Virus (EBV) Infection With Related Donor EBV Cytotoxic T-Lymphocytes in Children, Adolescents and Young Adult Recipients
Conditions
Interventions
cytotoxic t-lymphocytes
Locations
8
United States
Children's Hosptial Los Angeles
Los Angeles, California, United States
University of California San Francisco
San Francisco, California, United States
Johns Hopkins
Baltimore, Maryland, United States
Washington University
St Louis, Missouri, United States
New York Medical College
Valhalla, New York, United States
Nationwide Children's Hosptial
Columbus, Ohio, United States
Start Date
July 7, 2020
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2027
Last Updated
August 8, 2025
NCT03258567
NCT04232085
NCT03266627
NCT04197596
NCT06027879
NCT04354129
Lead Sponsor
New York Medical College
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions